Developing Multi-Specific Autologous T Cell Therapy Targeting Tumour Neoantigens

Time: 9:30 am
day: Day Two

Details:

  • Understanding pokeAcell’s ImmPACT technology – Simple expansion of neoantigen-specific T cells directly from blood
  • Exploring how AI-predicted neoantigens are utilised to generate a multi-specific polyclonal functional T cell product

Speakers: